Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2020 3
2021 2
2022 1
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
LINC01605 Is a Novel Target of Mutant p53 in Breast and Ovarian Cancer Cell Lines.
Coan M, Toso M, Cesaratto L, Rigo I, Borgna S, Dalla Pietà A, Zandonà L, Iuri L, Zucchetto A, Piazza C, Baldassarre G, Spizzo R, Nicoloso MS. Coan M, et al. Among authors: dalla pieta a. Int J Mol Sci. 2023 Sep 6;24(18):13736. doi: 10.3390/ijms241813736. Int J Mol Sci. 2023. PMID: 37762037 Free PMC article.
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.
Dalla Pietà A, Carpanese D, Grigoletto A, Tosi A, Dalla Santa S, Pedersen GK, Christensen D, Meléndez-Alafort L, Barbieri V, De Benedictis P, Pasut G, Montagner IM, Rosato A. Dalla Pietà A, et al. Cell Mol Immunol. 2021 May;18(5):1197-1210. doi: 10.1038/s41423-021-00667-y. Epub 2021 Mar 24. Cell Mol Immunol. 2021. PMID: 33762685 Free PMC article.
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer.
Montagner IM, Merlo A, Carpanese D, Dalla Pietà A, Mero A, Grigoletto A, Loregian A, Renier D, Campisi M, Zanovello P, Pasut G, Rosato A. Montagner IM, et al. Among authors: dalla pieta a. J Control Release. 2016 Aug 28;236:79-89. doi: 10.1016/j.jconrel.2016.06.033. Epub 2016 Jun 26. J Control Release. 2016. PMID: 27356018 Free article.
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling.
Bergamo F, Dalla Santa S, Loupakis F, Cerma K, Tosi A, De Grandis C, Dalla Pietà A, Gringeri E, Angerilli V, Ramondo G, Rago A, Cecchi F, Benz S, Cillo U, Dei Tos AP, Zagonel V, Fassan M, Rosato A, Lonardi S. Bergamo F, et al. Among authors: dalla pieta a. Front Oncol. 2022 Dec 8;12:964219. doi: 10.3389/fonc.2022.964219. eCollection 2022. Front Oncol. 2022. PMID: 36578937 Free PMC article.
Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases.
De Nardo L, Santi S, Dalla Pietà A, Ferro-Flores G, Azorín-Vega E, Nascimbene E, Barbieri V, Zorz A, Rosato A, Meléndez-Alafort L. De Nardo L, et al. Among authors: dalla pieta a. EJNMMI Phys. 2024 Nov 13;11(1):94. doi: 10.1186/s40658-024-00696-2. EJNMMI Phys. 2024. PMID: 39535653 Free PMC article.